Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosome injection during laparoscopic niche repair for cesarean scar pregnancy
IRCT20091012002576N38Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of endothelial progenitor cell-derived exosomes in cesarean scar pregnancy (CSEP) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Scar site length by vaginal sonogram at 6 weeks and Scar site width by vaginal sonogram at 6 weeks. Started Mar 2024; status: completed.
02
Drugs
endothelial progenitor cell-derived exosomes
03
Conditions
cesarean scar pregnancy (CSEP)
Beyond the preview
Go deeper on IRCT20091012002576N38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N38.